| Literature DB >> 33262355 |
Moritz Mirna1, Nana-Yaw Bimpong-Buta2, Fabian Hoffmann3,4, Thaer Abusamrah2, Thorben Knost2, Oliver Sander5, Yayu Monica Hew6, Michael Lichtenauer1, Johanna M Muessig2, Raphael Romano Bruno2, Malte Kelm2, Jochen Zange3, Jilada Wilhelm3, Ulrich Limper3,7, Jens Jordan3,8, Jens Tank3, Christian Jung9.
Abstract
Although acute hypoxia is of utmost pathophysiologic relevance in health and disease, studies on its effects on both the macro- and microcirculation are scarce. Herein, we provide a comprehensive analysis of the effects of acute normobaric hypoxia on human macro- and microcirculation. 20 healthy participants were enrolled in this study. Hypoxia was induced in a normobaric hypoxia chamber by decreasing the partial pressure of oxygen in inhaled air stepwisely (pO2; 21.25 kPa (0 k), 16.42 kPa (2 k), 12.63 kPa (4 k) and 9.64 kPa (6 k)). Macrocirculatory effects were assessed by cardiac output measurements, microcirculatory changes were investigated by sidestream dark-field imaging in the sublingual capillary bed and videocapillaroscopy at the nailfold. Exposure to hypoxia resulted in a decrease of systemic vascular resistance (p < 0.0001) and diastolic blood pressure (p = 0.014). Concomitantly, we observed an increase in heart rate (p < 0.0001) and an increase of cardiac output (p < 0.0001). In the sublingual microcirculation, exposure to hypoxia resulted in an increase of total vessel density, proportion of perfused vessels and perfused vessel density. Furthermore, we observed an increase in peripheral capillary density. Exposure to acute hypoxia results in vasodilatation of resistance arteries, as well as recruitment of microvessels of the central and peripheral microcirculation. The observed macro- and microcirculatory effects are most likely a result from compensatory mechanisms to ensure adequate tissue oxygenation.Entities:
Year: 2020 PMID: 33262355 PMCID: PMC7708486 DOI: 10.1038/s41598-020-77724-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic representation of the conducted measurements during the two hypoxia tests. TVD total vessel density, PPV proportion of perfused vessels, PVD perfused vessel density, PCD peripheral capillary recruitment, CD peripheral capillary diameter, SV stroke volume, HR heart rate, CO cardiac output, SBP systolic blood pressure, DBP diastolic blood pressure, SVR systemic vascular resistance, TSI tissue saturation index, THb total hemoglobin concentration.
Baseline characteristics of the subjects enrolled.
| % | n (total = 20) | |
|---|---|---|
| Sex (% male) | 55 | 11 |
Figure 2Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), stroke volume (SV), systemic vascular resistance (SVR), cardiac output (CO) and cardiac performance index (CPI) throughout the altitude simulation test. *p < 0.05, **p < 0.01 and ***p < 0.001.
Investigated variables throughout the altitude simulation tests.
| 50 m (0 k) | 2000 m (2 k) | 4000 m (4 k) | 6000 m (6 k) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Median | IQR | Median | IQR | Median | IQR | Median | IQR | ||
| Red blood cell count (per pL) | 4.9 | 4.3–5.5 | 4.9 | 4.2–5.4 | 4.9 | 4.3–5.4 | 4.9 | 4.3–5.3 | 0.984 |
| Hemoglobin (g/dl) | 14.8 | 12.9–15.7 | 14.4 | 13.0–15.7 | 14.5 | 12.8–15.5 | 14.6 | 12.7–15.5 | 0.944 |
| Arterial oxygen content (ml/dl) | 20.7 | 18.2–22.2 | 19.2 | 17.1–21.7 | 17.3 | 15.3–19.0 | 15.7 | 13.6–17.4 | < 0.0001 |
| Oxygen delivery (ml/min) | 1105 | 971.8–1189 | 1069 | 950.4–1209 | 1040 | 916.4–1139 | 1128 | 977.2–1255 | 0.455 |
| Peripheral oxygen saturation (%) | 97 | 97–97.5 | 95 | 93–97 | 84 | 80–87 | 80 | 67–83.5 | < 0.0001 |
| Respiratory rate (breaths per minute) | 16 | 14–16 | 18 | 16–18 | 18 | 16–22 | 24 | 21–28 | < 0.0001 |
| Systolic blood pressure (mmHg) | 115 | 105–130 | 114 | 103–122 | 116 | 103–119 | 110 | 104–122 | 0.251 |
| Diastolic blood pressure (mmHg) | 70 | 63–76 | 68 | 58–75 | 66 | 64–70 | 65 | 63–74 | 0.014 |
| Systemic vascular resistance (dynes*s/cm5) | 1206 | 1072–1421 | 1199 | 982–1352 | 1067 | 951–1152 | 940 | 814–1125 | < 0.0001 |
| Heart rate (bpm) | 65 | 60–70 | 66 | 61–72 | 76 | 69–86 | 80 | 73–92 | < 0.0001 |
| Stroke volume (ml) | 83 | 77–91 | 84 | 78–93 | 82 | 76–89 | 87 | 78–93 | 0.281 |
| Cardiac output (l/min) | 5.35 | 4.60–6.08 | 5.56 | 4.80–6.40 | 6.00 | 5.60–7.00 | 7.20 | 5.60–8.10 | < 0.0001 |
| Cardiac performance index (l/min/m2 BSA) | 0.51 | 0.48–0.59 | 0.53 | 0.48–0.63 | 0.60 | 0.54–0.69 | 0.67 | 0.53–0.75 | < 0.0001 |
| Perfused number of crossings | 32 | 27–37 | 33 | 27–40 | 35 | 29–39 | 36 | 30–42 | < 0.0001 |
| Perfused vessel density (mm/mm2) | 6.8 | 5.7–7.8 | 7.0 | 5.7–8.5 | 7.4 | 6.2–8.3 | 7.7 | 6.4–8.9 | < 0.0001 |
| Proportion of perfused vessels (%) | 94 | 89–97 | 94 | 89–98 | 95 | 90–98 | 95 | 91–100 | 0.017 |
| Number of crossings | 34 | 30–39 | 36 | 30–42 | 37 | 31–42 | 39 | 32–44 | < 0.0001 |
| Total vessel density (mm/mm2) | 7.2 | 6.4–8.3 | 7.7 | 6.4–8.9 | 7.9 | 6.6–8.9 | 8.3 | 6.9–9.4 | < 0.0001 |
Figure 3Perfused number of crossings (PNC), perfused vessel density (PVD), proportion of perfused vessels (PPV), number of crossings (NC), total vessel density (TVD), and peripheral capillary recruitment (PCD) throughout the altitude simulation test. *p < 0.05, **p < 0.01 and ***p < 0.001.
Figure 4Tissue saturation index (TSI), Delta-TSI and total hemoglobin concentration (THb) of the tongue and the vastus lateralis muscle throughout the hypoxia test. † denotes the t-test of vastus lat. versus tongue at 4 k, where the p value was < 0.05; ‡ denotes the t-tests of the tongue and vastus lat. at 4 k versus 0 k, where the p value was < 0.01; § denotes the t-test of the tongue at 6 k versus 0 k, where the p value was < 0.05. *p < 0.05, **p < 0.01 and ***p < 0.001.